source
- Enliven prices $400M offering; Jazz drug Zepzelca fails confirmatory studyPlus news about Caribou, Adial, and the Beneluxa Initiative. 💵 Enliven Therapeutics’ data and raise: The Burlingame, CA-based biotech priced a $400 million offering {$ELVN} Thursday night after sa…Endpoints · 1mo ago↗ source
- Biopharma's pay oddities of 2025: Executive perks and eccentricitiesIn combing through thousands of C-suite pay packages worth billions of dollars, it’s rare for a line item to stick out. Every once in a while, a biopharma company discloses perks that go beyond the…Endpoints · 1mo ago↗ source
- WuXi AppTec sues Pentagon in challenge over inclusion on Chinese military listWuXi AppTec has lodged a claim against the Department of Defense following its addition to a list of companies associated with the Chinese military. Under the complaint, filed Thursday with the US…